DNMT3A and myelodysplastic syndrome: We and others have identified isolated CH mutations, predominantly in DNMT3A and TET2, in 50% of MDS cases with VEXAS syndrome (6 out of 12 cases in total, DNMT3A mutation in 2, TET2 mutation in 2) [41, 42].